The use of a novel tobacco-substitute sheet and smoke dilution to reduce toxicant yields in cigarette smoke

Food and Chemical Toxicology

Volumn 49, Issue 8, 2011, Pages 1684-1696

  McAdam , K G ^a   Gregg, E O ^b   Liu, C ^a   Dittrich, D J ^a   Duke, M G ^a   Proctor, C J ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b ENI Limited   (United Kingdom)

Author keywords

Biomarkers; Filter studies; Smoke toxicants; Tobacco substitute

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; GLYCEROL; NICOTINE;

ADULT; ANIMAL CELL; ARTICLE; CIGARETTE SMOKING; DILUTION; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; FEMALE; FILTER; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; PARTICULATE MATTER; SMOKE; TOBACCO SUBSTITUTE SHEET; TOXICITY TESTING; URINALYSIS;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CROSS-OVER STUDIES; FEMALE; FILTRATION; GLYCEROL; HAZARDOUS SUBSTANCES; HUMANS; MALE; MICE; MICRONUCLEUS TESTS; MIDDLE AGED; NICOTINE; NITROSAMINES; PYRENES; PYRIDINES; SINGLE-BLIND METHOD; SMOKE; TOBACCO; TOBACCO SMOKE POLLUTION; TOXICITY TESTS; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 79958754579     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.002     Document Type: Article

References (58)

1. Alexandrie A.K., Warholm M., Carstensen U., Axmon A., Hagmar L., Levin J.O., Ostman C., Rannug A. CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 2000, 21:669-676.
2. Apostoli P., Neri G., Lucas D., Manno M., Berthou F. Influence of genetic polymorphisms of CYP1A1 and GSTM1 on the urinary levels of 1-hydroxypyrene. Toxicol. Lett. 2003, 144(1):27-34.
3. Baker R.R. Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health. Prog. Energy Combust. Sci. 2006, 32:373-385.
4. Baker R.R. The generation of formaldehyde in cigarettes - Overview and recent experiments. Food Chem. Toxicol. 2006, 44:1799-1822.
5. Baker R.R., Massey E.D., Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 2004, 42:S53-S83.
6. Baker R.R., Coburn S., Liu C. The pyrolytic formation of formaldehyde from sugars and tobacco. J. Anal. Appl. Pyrrolysis 2006, 7:12-21.
7. Buchet J.P., Gennart J.P., Mercade-Calderon F., Delavignette J.P., Cupers L., Lauwerys R. Evaluation of exposure to PAHs in a coke production and graphite electrode manufacturing plant:assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure. Br. J. Ind. Med. 1992, 49:761-768.
8. Burns D., Dybing E., Gray N., Hecht S., Anderson C., Sanner T., O'Connor R., Djordjevic M., Dresler C., Hainaut P., Jarvis M., Opperhuizen A., Straif K. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 2008, 17:132-141.
9. Calapai G., Caputi A., Mannucci C., Gregg E., Puntoni R., Lowe F., Bassi A., Morandi S., Nunziata A. A cross-sectional study of biomarker of risk after a decade of smoking. Inhal. Toxicol. 2009, 21:1138-1143.
10. Carmella S.G., Han S., Fristad A., Yang Y., Hecht S.S. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol. Biom. Prev. 2003, 12:1257-1261.
11. Clive D., Bolcsfoldi G., Clements J., et al. Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ. Molec. Mutagenesis 1995, 25:165-168.
12. Coggins C.R., Gaworski C.L. Could charcoal filtration of cigarette smoke reduce smoking-induced disease? A review of the literature. Regul. Toxicol. Pharmacol. 2008, 50:359-365.
13. Commonwealth of Massachusetts, 1997. Tobacco disclosure act. Cigarette and smokeless tobacco products: reports of added constituents and nicotine ratings. General laws of Massachusetts, Chapter 94, Section 307B, 105 CMR 660.000.
14. Counts M.E., Morton M.J., Laffon S.W., Cox R.H., Lipowicz P.J. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 2005, 41:185-227.
15. Dittrich, D.J., Sutton, J.P., Coburn S, 2003a. Smoking articles and smokable filler thereof. WO/03-020056 A1, World Intellectual Property Organization.
16. Dittrich, D.J., Sutton, J.P., Coburn S., Figlar, J., 2003b. Improvements relating to smoking articles and smokable filler thereof. WO/03-092416 A1, World Intellectual Property Organization.
17. Dong J.Z., Glass J.N., Moldoveanu S.C. A simple GC-MS technique for the analysis of vapour phase mainstream cigarette smoke. J. Microcol. Sep. 2000, 12(3):142-152.
18. Cigarettes: testing for tar and nicotine content. Fed. Regist. 1967, 32:11178. Federal Trade Commission.
19. Fowles J., Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 2003, 12(4):424-430.
20. Froggatt P. Determinants of policy on smoking and health. Int. J. Epidemiol. 1989, 18:1-9.
21. Gardner D.E. A safer cigarette? A comparative study. A consensus report. Eclipse Expert. Panel. Inhal. Toxicol. 2000, 12(Suppl. 5):1-58.
22. Green C.R., Schumacher J.N., Lloyd R.A., Rodgman A. Comparison of the composition of tobacco smoke and the smokes from various tobacco substitutes. Beit. Tabakforsch. Intl. 2007, 22:258-289.
23. Gregg E., Hill C., Hollywood M., Kearney M., McAdam K., Purkis S., McLaughlin D., Williams M. The UK smoke constituents testing study. Summary of results and comparison with other studies. Beit. Tabakforsch. Intl. 2004, 21:117-118.
24. Gregg E.O., Fisher A.-L., Lowe F., McEwan M., Massey E.D. An approach to the validation of biomarkers of harm for use in a tobacco context. Reg. Toxicol. Pharmacol. 2006, 44:262-267.
25. Hatsukami D.K., Hanson K., Briggs A., Parascandola M., Genkinger J.M., O'Connor R., Shields P.G. Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiol. Biom. Prev. 2009, 18(12):3143-3195.
26. Health Canada, 1999. Determination of "Tar" and Nicotine in Sidestream Tobacco Smoke. T-212. Available at: http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/tobac-tabac/legislation/reg/indust/method/_side-second/nicotine-eng.pdf.
27. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002, 23(6):907-922.
28. Hecht S.S., Carmella S.G., Chen M., Koch J.F.D., Miller A.T., Murphy S.E., Jensen J.A., Zimmerman C.L., Hatsukami D.K. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 1999, 59:590-596.
29. Heck J.D., Gaworski C.L., Rajendran N., Morrissey R.L. Toxicologic evaluation of humectants added to cigarette tobacco: 13-week smoke inhalation study of glycerin and propylene glycol in Fischer 344 rats. Inhal. Toxicol. 2002, 14:1135-1152.
30. Hoffmann D., Wynder E. Filtration of phenols from tobacco smoke. J. Natl. Cancer Inst. 1963, 30:67-84.
31. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 2001, 14:767-790.
32. ICH (International Conference on Harmonisation), 2008. S2(R1): Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. Available at: http://www.ich.org/cache/compo/276-254-1.html.
33. ISCSH (Independent Scientific Committee on Smoking and Health), 1988. Fourth report of the Independent Scientific Committee on Smoking and Health. Her Majesty's Stationary Office, London.
34. Ishidate M., Sofuni T., Yoshikawa M., Nohmi T., Sawada M., Matsuoka A. Primary mutagenicity screening of food additives currently used in Japan. Fd. Chem. Toxicol. 1984, 22:623-636.
35. ISO 3308, 2000. Routine Analytical Smoking Machine - Definition and Standard Conditions. International Organisation for Standardisation, Geneva.
36. ISO 3402, 1999. Tobacco and tobacco products - Atmosphere for conditioning and testing; International Organisation for Standardisation, Geneva.
37. ISO 4387, 2000. Cigarettes - Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine, International Organisation for Standardisation, Geneva.
38. JECFA (Joint Expert Committee on Food Additives), 1976. WHO Food Additives Series No 10, WHO Publications, Geneva.
39. Lee C.K., Doolittle D.J., Burger G.T., Hayes A.W. Comparative genotoxicity testing of mainstream whole smoke from cigarettes which burn or heat tobacco. Mutat. Res. 1990, 242(1):37-45.
40. Liu C. Glycerol transfer in cigarette mainstream smoke. Beit. Tabakforsch. Intl. 2004, 21:111-116.
41. Lowe F.J., Gregg E.O., McEwan M. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clin. Chem. Lab. Med. 2009, 47(3):311-320.
42. US National Cancer Institute, 2001. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control, Monograph 13, October 2001.
43. NIH (National Institutes of Health), 2001. Guidance document on using in vitro data to estimate in vivo starting doses for acute toxicity. Publication 01-4500. National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Public Health Service, Washington, D.C.
44. OECD (Organisation for Economic Cooperation and Development), Environmental Directorate, 1979. Guidelines for the testing of chemicals, Summary.
45. OECD, 1997a. Guidelines for the testing of chemicals, Guideline 471, Bacterial Reverse Mutation assay.
46. OECD, 1997b. Guidelines for the testing of chemicals, Guideline 476, in vitro mammalian cell gene mutation test.
47. OECD, 2007. OECD guideline for the testing of chemicals. Draft Proposal for a New Guideline 487: In Vitro Mammalian Cell Micronucleus Test (MNvit).
48. Patskan G., Reininghaus W. Toxicological evaluation of and electrically heated cigarette. Part I: overview of technical aspects and summary of findings. J. Appl. Toxicol. 2003, 23:329-339.
49. Renne R.A. 2-week and 13-week inhalation studies of aerosolized glycerol in rats. Inhal. Toxicol. 1992, 4:95-111.
50. Rodgman A., Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke 2009, CRC Press, Boca Raton.
51. Shepperd, C.J., Mariner, D.C., 2001. A Study to Estimate the Amounts of Tar and Nicotine Delivered to UK Smokers of 1-11mg Products, in Laboratory and 'Home' Environments. 55th Tobacco Science Research Conference, Greensboro, NC, paper 71.
52. Shepperd C.J., St Charles F.K., Lien M., Dixon M. Validation of methods for determining consumer smoked cigarette yields from cigarette filter analysis. Beitr. Tabakforsch. Intl. 2006, 22:176-184.
53. St Charles, F.K., 2001. A robust method for determining consumer smoked cigarette yields from filter analytical data. Paper presented at the 55th Tobacco Science Research Conference, Greensboro, NC, paper 92.
54. Clearing the smoke. Assessing the science base for tobacco harm reduction 2001, National Academy Press, Washington, D.C. K. Stratton, P. Shetty, R. Wallace, S. Bondurant (Eds.).
55. Tokida A., Atobe I., Maeda K. Adsorption of the vapour phase components in cigarette smoke by activated carbon in vented filters. Agricul. Biol. Chem. 1985, 49:3109-3113.
56. Vanscheeuwijck P.M., Teredesai A., Terpstra P.M., Verbeeck J., Kuhl P., Gerstenberg B., Gebel S., Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol. 2002, 40:113-131.
57. Waller, R.E., Froggatt, P., 1996. Product modification. In: R. Doll, J. Crofton (Eds.), Tobacco and Health Br. Med. Bull. vol. 52, pp. 193-205.
58. Wilson J., Clapp M.J.L., Conning D.M. Effect of glycerol on local and systemic carcinogenicity of topically applied tobacco condensate. Br. J. Cancer 1978, 38:250-257.